Revelation Biosciences, Inc.
REVB · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $4 | $2 | $8 | $8 |
| - Cash | $13 | $5 | $4 | $6 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | -$9 | -$3 | $4 | $1 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$2 | -$2 | -$2 | -$2 |
| % Margin | – | – | – | – |
| Net Income | -$2 | -$2 | -$2 | -$2 |
| % Margin | – | – | – | – |
| EPS Diluted | -1.77 | -7.01 | -2.11 | -4.98 |
| % Growth | 74.8% | -232.2% | 57.6% | – |
| Operating Cash Flow | -$2 | -$2 | -$3 | -$4 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$2 | -$2 | -$3 | -$4 |